Diagnosis of prostate cancer via nanotechnological approach

References

• SiegelRLMillerKDJemalACancer statistics, 2015CA Cancer J Clin20156552925559415
   PubMed Web of Science ®Google Scholar
• FerlayJSteliarova-FoucherELortet-TieulentJCancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012Eur J Cancer2013491374140323485231
   PubMed Web of Science ®Google Scholar
• HumphreyPAGleason grading and prognostic factors in carcinoma of the prostateMod Pathol20041729230614976540
   PubMed Web of Science ®Google Scholar
• GleasonDFHistologic grading and staging of prostatic-carcinomaAm J Surg Pathol19815193193
   Google Scholar
• AmisESJrBigongiariLRBluthEIPretreatment staging of clinically localized prostate cancer. American College of Radiology. ACR Appropriateness CriteriaRadiology2000215suppl70370811037488
   PubMedGoogle Scholar
• ChungMSLeeSHLeeDHChungBHEvaluation of the 7th American Joint Committee on cancer TNM staging system for prostate cancer in point of classification of bladder neck invasionJpn J Clin Oncol20134318418823225909
   PubMedGoogle Scholar
• DashASandaMGYuMTaylorJMFeckoARubinMAProstate cancer involving the bladder neck: recurrence-free survival and implications for AJCC staging modification. American Joint Committee on CancerUrology20026027628012137826
   PubMed Web of Science ®Google Scholar
• HanMWalshPCPartinAWRodriguezRAbility of the 1992 and 1997 American Joint Committee on Cancer staging systems for prostate cancer to predict progression-free survival after radical prostatectomy for stage T2 diseaseJ Urol2000164899210840430
   PubMedGoogle Scholar
• IyerRVHanlonALPinoverWHHanksGEOutcome evaluation of the 1997 American Joint Committee on cancer staging system for prostate carcinoma treated by radiation therapyCancer1999851816182110223577
   PubMedGoogle Scholar
• TaylorSHMerrimanKWSpiessPEPistersLInadequacies of the current American Joint Committee on cancer staging system for prostate cancerCancer200610655956516369982
   PubMedGoogle Scholar
• ZaorskyNGLiTDevarajanKHorwitzEMBuyyounouskiMKAssessment of the American Joint Committee on Cancer staging (sixth and seventh editions) for clinically localized prostate cancer treated with external beam radiotherapy and comparison with the National Comprehensive Cancer Network risk-stratification methodCancer20121185535554322544661
   PubMed Web of Science ®Google Scholar
• MooreSKuhrikMKuhrikNSheaLScreening for prostate cancer: PSA blood test, rectal examination, and ultrasoundUrol Nurs1992121061071382318
   PubMedGoogle Scholar
• CrawfordEDDeAntoniEPPSA as a screening test for prostate cancerUrol Clin North Am1993206376467505971
   PubMedGoogle Scholar
• HalperinECScreening for prostate cancer utilizing the prostate-specific antigen (PSA)N C Med J1993544434467694161
   PubMedGoogle Scholar
• MarksLSFradetYDerasILPCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsyUrology20076953253517382159
   PubMed Web of Science ®Google Scholar
• HaeseAde la TailleAvan PoppelHClinical utility of the PCA3 urine assay in European men scheduled for repeat biopsyEur Urol2008541081108818602209
   PubMed Web of Science ®Google Scholar
• MeariniEAntognelliCDel BuonoCThe combination of urine DD3(PCA3) mRNA and PSA mRNA as molecular markers of prostate cancerBiomarkers20091423524319489685
   PubMed Web of Science ®Google Scholar
• PepePAragonaFPCA3 score vs PSA free/total accuracy in prostate cancer diagnosis at repeat saturation biopsyAnticancer Res2011314445444922199313
   PubMedGoogle Scholar
• PerdonàSCavadasVDi LorenzoGProstate cancer detection in the “grey area” of prostate-specific antigen below 10 ng/mL: head-to-head comparison of the updated PCPT calculator and Chun’s nomogram, two risk estimators incorporating prostate cancer antigen 3Eur Urol201159818720947244
   PubMed Web of Science ®Google Scholar
• MelicharBPSA, PCA3 and the philosophy of prostate cancer managementClin Chem Lab Med20135170771223518451
   PubMed Web of Science ®Google Scholar
• ShinoharaKImproving cancer detection by prostate biopsy: the role of core number and siteNat Clin Pract Urol2006352652717031375
   PubMedGoogle Scholar
• ElabbadyAAKhedrMMExtended 12-core prostate biopsy increases both the detection of prostate cancer and the accuracy of Gleason scoreEur Urol2006494953 discussion 5316314035
   PubMed Web of Science ®Google Scholar
• CampodonicoFCasaricoAGavazziLCancer detection with TRUS-guided 10-core biopsy of the prostate. an institutional assessment at the first, repeated and surgical specimen biopsyArch Ital Urol Androl200678394316929600
   PubMedGoogle Scholar
• SinghHCantoEIShariatSFImproved detection of clinically significant, curable prostate cancer with systematic 12-core biopsyJ Urol20041711089109214767277
   PubMed Web of Science ®Google Scholar
• NarayanPJajodiaPSteinRCore biopsy instrument in the diagnosis of prostate cancer: superior accuracy to fine needle aspirationJ Urol19911457957972005704
   PubMedGoogle Scholar
• SpaanderPJMostofiKBlomJBiopsy techniques and cytology in prostate cancerProg Clin Biol Res19903571571582217459
   PubMedGoogle Scholar
• LeeFLittrupPJMcLearyRDNeedle aspiration and core biopsy of prostate cancer: comparative evaluation with biplanar transrectal US guidanceRadiology19871635155203550883
   PubMedGoogle Scholar
• GreenLDigital rectal examination screening for prostate cancerJAMA19932701315 author reply 1315-68360960
   PubMedGoogle Scholar
• GerberGSChodakGWDigital rectal examination in the early detection of prostate cancerUrol Clin North Am1990177397442219574
   PubMed Web of Science ®Google Scholar
• ChodakGWKellerPSchoenbergHWAssessment of screening for prostate cancer using the digital rectal examinationJ Urol1989141113611382709500
   PubMed Web of Science ®Google Scholar
• Torp-PedersenSTLittrupPJLeeFMettlinCEarly prostate cancer: diagnostic costs of screening transrectal US and digital rectal examinationRadiology19881693513543140290
   PubMedGoogle Scholar
• ChodakGWKellerPSchoenbergHRoutine screening for prostate cancer using the digital rectal examinationProg Clin Biol Res198826987983393557
   PubMedGoogle Scholar
• GhaiSToiARole of transrectal ultrasonography in prostate cancerRadiol Clin North Am2012501061107323122038
   PubMedGoogle Scholar
• KostakopoulosAPikraminosDLissiotisPMalachiasGStavropoulosNIKontothanasisDThe contribution of transrectal ultrasonography in the early diagnosis of prostate cancerActa Urol Belg19926057631384290
   PubMedGoogle Scholar
• WilsonTMGuthmanDACurrent status of transrectal ultrasonography in the detection of prostate cancerOncology (Williston Park)199157378 discussion 831828689
   PubMedGoogle Scholar
• HernandezADSmithJAJrTransrectal ultrasonography for the early detection and staging of prostate cancerUrol Clin North Am1990177457572219575
   PubMedGoogle Scholar
• FujinoAScardinoPTTransrectal ultrasonography for prostatic cancer. II. The response of the prostate to definitive radiotherapyCancer1986579359403510709
   PubMed Web of Science ®Google Scholar
• PeelingWBGriffithsGJEvansKTRobertsEEDiagnosis and staging of prostatic cancer by transrectal ultrasonography. A preliminary studyBr J Urol19795156556993975
   PubMedGoogle Scholar
• HubenRPMurphyGPTransrectal ultrasonography of the prostate and prostate cancer – an updateAppl Pathol198531982053916055
   PubMedGoogle Scholar
• ResnickMIWillardJWBoyceWHTransrectal ultrasonography in the evaluation of patients with prostatic carcinomaJ Urol19801244824847420589
   PubMed Web of Science ®Google Scholar
• CarpentierPJSchroederFHBlomJHTransrectal ultrasonography in the followup of prostatic carcinoma patientsJ Urol19821287427467143595
   PubMedGoogle Scholar
• CarpentierPJSchroderFHTransrectal ultrasonography in the followup of prostatic carcinoma patients: a new prognostic parameter?J Urol19841319039056708224
   PubMed Web of Science ®Google Scholar
• FujinoAScardinoPTTransrectal ultrasonography for prostatic cancer: its value in staging and monitoring the response to radiotherapy and chemotherapyJ Urol19851338068103886938
   PubMed Web of Science ®Google Scholar
• PontesJEEisenkraftSWatanabeHOheHSaitohMMurphyGPPreoperative evaluation of localized prostatic carcinoma by transrectal ultrasonographyJ Urol19851342892913894694
   PubMed Web of Science ®Google Scholar
• RifkinMDTransrectal prostatic ultrasonography: comparison of linear array and radial scannersJ Ultrasound Med19854152579244
   PubMedGoogle Scholar
• DevonecMDiagnostic value of transrectal ultrasonography in prostatic cancerProg Clin Biol Res1987243B1103309977
   PubMedGoogle Scholar
• RorvikJServollEHalvorsenOJTransrectal ultrasonography in the staging of localized prostatic carcinoma. A pilot studyScand J Urol Nephrol19922615191631502
   PubMed Web of Science ®Google Scholar
• MottetNLehmannMCicorelliSTransrectal ultrasonography in prostatic cancer: interexaminer variability of interpretationEur Urol1997321501549286644
   PubMedGoogle Scholar
• PrakashVSMohanGCKrishnaiahSVTen-core versus 16-core transrectal ultrasonography guided prostate biopsy for detection of pro-static carcinoma: a prospective comparative study in Indian populationProstate Int2013116316824392441
   PubMedGoogle Scholar
• FowlerJEJrMillsSEOperable prostatic carcinoma: correlations among clinical stage, pathological stage, Gleason histological score and early disease-free survivalJ Urol198513349523964879
   PubMedGoogle Scholar
• WooSKaplanIRoachMBagshawMFormula to estimate risk of pelvic lymph node metastasis from the total Gleason score for prostate cancerJ Urol19881403873398155
   PubMedGoogle Scholar
• PartinAWYooJCarterHBThe use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancerJ Urol19931501101147685418
   PubMed Web of Science ®Google Scholar
• WolfJSJrShinoharaKCarrollPRNarayanPCombined role of transrectal ultrasonography, Gleason score, and prostate-specific antigen in predicting organ-confined prostate cancerUrology1993421311377690168
   PubMedGoogle Scholar
• NarayanPGajendranVTaylorSPThe role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancerUrology1995462052127542823
   PubMedGoogle Scholar
• ThickmanDSpeersWCPhilpottPJShapiroHEffect of the number of core biopsies of the prostate on predicting Gleason score of prostate cancerJ Urol19961561101138648769
   PubMedGoogle Scholar
• FernandesETSundaramCPLongRSoltaniMErcoleCJBiopsy Gleason score: how does it correlate with the final pathological diagnosis in prostate cancer?Br J Urol1997796156179126095
   PubMedGoogle Scholar
• JeongIGLimJHYouDIncremental value of magnetic resonance imaging for clinically high risk prostate cancer in 922 radical prostatectomiesJ Urol20131902054206023791890
   PubMedGoogle Scholar
• PilepichMVKrallJMal-SarrafMAndrogen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology GroupUrology1995456166237716842
   PubMed Web of Science ®Google Scholar
• WalshPCImmediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council Trial. The Medical Research Council Prostate Cancer Working Party Investigators GroupBr J Urol1997792352469052476
   PubMedGoogle Scholar
• BollaMGonzalezDWardePImproved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelinN Engl J Med19973372953009233866
   PubMed Web of Science ®Google Scholar
• HillBKyprianouNSequencing hormonal ablation and radiotherapy in prostate cancer: a molecular and therapeutic perspective (Review)Oncol Rep200291151115612375010
   PubMedGoogle Scholar
• HugginsCHodgesCVStudies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941J Urol200216891212050481
   PubMed Web of Science ®Google Scholar
• StuderUEHauriDHanselmannSImmediate versus deferred hormonal treatment for patients with prostate cancer who are not suitable for curative local treatment: results of the randomized trial SAKK 08/88J Clin Oncol2004224109411815483020
   PubMed Web of Science ®Google Scholar
• MessingEMManolaJYaoJEastern Cooperative Oncology Group Study EST 3886Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomyLancet Oncol2006747247916750497
   PubMed Web of Science ®Google Scholar
• GleaveMKlotzLTanejaSSThe continued debate: intermittent vs continuous hormonal ablation for metastatic prostate cancerUrol Oncol200927818619111804
   PubMedGoogle Scholar
• EllisRJKaminskyDAZhouEHTen-year outcomes: the clinical utility of single photon emission computed tomography/computed tomography capromab pendetide (Prostascint) in a cohort diagnosed with localized prostate cancerInt J Radiat Oncol Biol Phys201181293420961696
   PubMedGoogle Scholar
• SodeeDBConantRChalfantMPreliminary imaging results using In-111 labeled CYT-356 (Prostascint) in the detection of recurrent prostate cancerClin Nucl Med1996217597678896922
   PubMed Web of Science ®Google Scholar
• ShrevePDGrossmanHBGrossMDWahlRLMetastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucoseRadiology19961997517568638000
   PubMed Web of Science ®Google Scholar
• SanzGRiojaJZudaireJJBerianJMRichterJAPET and prostate cancerWorld J Urol20042235135215503049
   PubMedGoogle Scholar
• ReskeSNBlumsteinNMNeumaierBImaging prostate cancer with 11C-choline PET/CTJ Nucl Med2006471249125416883001
   PubMed Web of Science ®Google Scholar
• MintzAPET/CT in prostate cancer: an unmet clinical needOncology (Williston Park)2014281065106625738198
   PubMedGoogle Scholar
• JadvarHPSMA PET in prostate cancerJ Nucl Med20155681131113225977465
   PubMedGoogle Scholar
• de KoningHJSchroderFHPSA screening for prostate cancer: the current controversyAnn Oncol19989129312969932158
   PubMedGoogle Scholar
• McCarthyMPSA screening said to reduce prostate-cancer deaths, or does it?Lancet1998351156310326552
   PubMedGoogle Scholar
• CatalonaWJSmithDSRatliffTLMeasurement of prostate-specific antigen in serum as a screening-test for prostate-cancerN Engl J Med1991324115611611707140
   PubMed Web of Science ®Google Scholar
• BrettonPRProstate-specific antigen and digital rectal examination in screening for prostate cancer: a community-based studySouth Med J1994877207237517580
   PubMedGoogle Scholar
• CatalonaWJRichieJPAhmannFRComparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 menJ Urol1994151128312907512659
   PubMed Web of Science ®Google Scholar
• ThompsonIMPaulerDKGoodmanPJPrevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliterN Engl J Med20043502239224615163773
   PubMed Web of Science ®Google Scholar
• SchroderFHvan der Cruijsen-KoeterIde KoningHJVisANHoedemaekerRFKranseRProstate cancer detection at low prostate specific antigenJ Urol200016380681110687982
   PubMed Web of Science ®Google Scholar
• TumaRSNew tests for prostate cancer may be nearing the clinicJ Natl Cancer Inst201010275275420498428
   PubMedGoogle Scholar
• SchröderFHHugossonJRoobolMJERSPC InvestigatorsScreening and prostate-cancer mortality in a randomized European studyN Engl J Med20093601320132819297566
   PubMed Web of Science ®Google Scholar
• AndrioleGLCrawfordEDGrubbRL3rdBuysSSProstate cancer screening in the randomized prostate, lung, colorectal, and ovarian cancer screening trial: mortality results after 13 years of follow-upJ Natl Cancer Inst201210412513222228146
   PubMed Web of Science ®Google Scholar
• Al-ShyoukhIYuFFengJSystematic quantitative characterization of cellular responses induced by multiple signalsBMC Syst Biol201158821624115
   PubMed Web of Science ®Google Scholar
• HrkachJVon HoffDMukkaram AliMPreclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profileSci Transl Med20124128ra39
   PubMed Web of Science ®Google Scholar
• WongPKYuFShahangianAChengGSunRHoCMClosed-loop control of cellular functions using combinatory drugs guided by a stochastic search algorithmProc Natl Acad Sci U S A20081055105511018356295
   PubMed Web of Science ®Google Scholar
• DawidczykCMKimCParkJHState-of-the-art in design rules for drug delivery platforms: Lessons learned from FDA-approved nanomedicinesJ Control Release2014187C13314424874289
   PubMedGoogle Scholar
• FerrariMCancer nanotechnology: opportunities and challengesNat Rev Cancer2005516117115738981
   PubMed Web of Science ®Google Scholar
• CondonADesigned DNA molecules: principles and applications of molecular nanotechnologyNat Rev Genet2006756557516770339
   PubMedGoogle Scholar
• SilvaGANeuroscience nanotechnology: progress, opportunities and challengesNat Rev Neurosci20067657416371951
   PubMed Web of Science ®Google Scholar
• Cancer nanotechnology: small, but heading for the big timeNat Rev Drug Discov2007617417517396287
   PubMedGoogle Scholar
• McCarthyNNanotechnology: tag teamsNat Rev Cancer20111153721753792
   PubMedGoogle Scholar
• SchroederAHellerDAWinslowMMTreating metastatic cancer with nanotechnologyNat Rev Cancer201212395022193407
   PubMed Web of Science ®Google Scholar
• SrikanthMKesslerJANanotechnology-novel therapeutics for CNS disordersNat Rev Neurol2012830731822526003
   PubMed Web of Science ®Google Scholar
• ErricoANew technology: nanotechnology targets cancer cellsNat Rev Clin Oncol20131066724129354
   PubMedGoogle Scholar
• HarrisonCNanotechnology: biological proteins knock nanoparticles off targetNat Rev Drug Discov20131226423493078
   PubMedGoogle Scholar
• SmithDMSimonJKBakerJRJrApplications of nanotechnology for immunologyNat Rev Immunol20131359260523883969
   PubMed Web of Science ®Google Scholar
• Axiak-BechtelSMUpendranALattimerJCGum arabic-coated radioactive gold nanoparticles cause no short-term local or systemic toxicity in the clinically relevant canine model of prostate cancerInt J Nanomedicine201495001501125378926
   PubMed Web of Science ®Google Scholar
• GaoXLuoYWangYProstate stem cell antigen-targeted nanoparticles with dual functional properties: in vivo imaging and cancer chemotherapyInt J Nanomedicine201274037405122888241
   PubMed Web of Science ®Google Scholar
• GobinAMMoonJJWestJLEphrinA1-targeted nanoshells for photothermal ablation of prostate cancer cellsInt J Nanomedicine2008335135818990944
   PubMed Web of Science ®Google Scholar
• SatoAItchoNIshiguroHMagnetic nanoparticles of Fe3O4 enhance docetaxel-induced prostate cancer cell deathInt J Nanomedicine201383151316023990723
   PubMed Web of Science ®Google Scholar
• TaylorRMSillerudLOPaclitaxel-loaded iron platinum stealth immunomicelles are potent MRI imaging agents that prevent prostate cancer growth in a PSMA-dependent mannerInt J Nanomedicine201274341435222915856
   PubMed Web of Science ®Google Scholar
• WuXDingBGaoJSecond-generation aptamer-conjugated PSMA-targeted delivery system for prostate cancer therapyInt J Nanomedicine201161747175621980237
   PubMed Web of Science ®Google Scholar
• WuXTaiZZhuQStudy on the prostate cancer-targeting mechanism of aptamer-modified nanoparticles and their potential anticancer effect in vivoInt J Nanomedicine201495431544025473281
   PubMed Web of Science ®Google Scholar
• YuanLLiuCChenYZhangZZhouLQuDAntitumor activity of tripterine via cell-penetrating peptide-coated nanostructured lipid carriers in a prostate cancer modelInt J Nanomedicine201384339435024235831
   PubMed Web of Science ®Google Scholar
• MouliSKZhaoLCOmaryRAThaxtonCSLymphotropic nanoparticle enhanced MRI for the staging of genitourinary tumorsNat Rev Urol20107849320084078
   PubMedGoogle Scholar
• MaLHeSHuangJCaoLYangFLiLMaximizing specificity and yield of PCR by the quantum dot itself rather than property of the quantum dot surfaceBiochimie20099196997319442702
   PubMed Web of Science ®Google Scholar
• RazzakMNanotechnology opens up new realm of detection in GBMNat Rev Clin Oncol201310423183633
   PubMedGoogle Scholar
• ParkHHwangMPLeeKHImmunomagnetic nanoparticle-based assays for detection of biomarkersInt J Nanomedicine201384543455224285924
   PubMed Web of Science ®Google Scholar
• ParkHHwangMPLeeJWChoiJLeeKHHarnessing immunomagnetic separation and quantum dot-based quantification capacities for the enumeration of absolute levels of biomarkerNanotechnology20132428510323787774
   PubMedGoogle Scholar
• HwangMPLeeJWLeeKELeeKHThink modular: a simple apoferritin-based platform for the multifaceted detection of pancreatic cancerACS Nano201378167817423988226
   PubMed Web of Science ®Google Scholar
• LeeJWSongJHwangMPLeeKHNanoscale bacteriophage biosensors beyond phage displayInt J Nanomedicine201383917392524143096
   PubMed Web of Science ®Google Scholar
• ChoiJParkSStojanovićZFacile solvothermal preparation of monodisperse gold nanoparticles and their engineered assembly of ferritin-gold nanoclustersLangmuir201329156981570324283573
   PubMedGoogle Scholar
• GallowayJFWinterALeeKHQuantitative characterization of the lipid encapsulation of quantum dots for biomedical applicationsNanomedicine201281190119922197728
   PubMedGoogle Scholar
• LeeKHGallowayJFParkJQuantitative molecular profiling of biomarkers for pancreatic cancer with functionalized quantum dotsNanomedicine201281043105122306154
   PubMed Web of Science ®Google Scholar
• ParkHLeeJWHwangMPLeeKHQuantification of cardiovascular disease biomarkers via functionalized magnetic beads and on-demand detachable quantum dotsNanoscale201358609861523893124
   PubMedGoogle Scholar
• DrabovichAPSaraonPJarviKDiamandisEPSeminal plasma as a diagnostic fluid for male reproductive system disordersNat Rev Urol20141127828824709963
   PubMed Web of Science ®Google Scholar
• ThomasCESextonWBensonKSutphenRKoomenJUrine collection and processing for protein biomarker discovery and quantificationCancer Epidemiol Biomarkers Prev20101995395920332277
   PubMed Web of Science ®Google Scholar
• BarrattJTophamPUrine proteomics: the present and future of measuring urinary protein components in diseaseCMAJ200717736136817698825
   PubMed Web of Science ®Google Scholar
• ZhouMLucasDAChanKCAn investigation into the human serum “interactome”Electrophoresis2004251289129815174051
   PubMed Web of Science ®Google Scholar
• LopezMFMikulskisAKuzdzalSHigh-resolution serum proteomic profiling of Alzheimer disease samples reveals disease-specific, carrier-protein-bound mass signaturesClin Chem2005511946195416081505
   PubMed Web of Science ®Google Scholar
• AyacheSPanelliMMarincolaFMStroncekDFEffects of storage time and exogenous protease inhibitors on plasma protein levelsAm J Clin Pathol200612617418416891190
   PubMed Web of Science ®Google Scholar
• DearJWStreetJMBaileyMAUrinary exosomes: a reservoir for biomarker discovery and potential mediators of intrarenal signallingProteomics2013131572158023129434
   PubMed Web of Science ®Google Scholar
• FliserDNovakJThongboonkerdVAdvances in urinary proteome analysis and biomarker discoveryJ Am Soc Nephrol2007181057107117329573
   PubMed Web of Science ®Google Scholar
• NolenBMLokshinAEThe advancement of biomarker-based diagnostic tools for ovarian, breast, and pancreatic cancer through the use of urine as an analytical biofluidInt J Biol Markers20112614115221928247
   PubMedGoogle Scholar
• BroedbaekKWeimannAStovgaardESPoulsenHEUrinary 8-oxo-7,8-dihydro-2′-deoxyguanosine as a biomarker in type 2 diabetesFree Radic Biol Med2011511473147921820047
   PubMed Web of Science ®Google Scholar
• KuJHGodoyGAmielGELernerSPUrine survivin as a diagnostic biomarker for bladder cancer: a systematic reviewBJU Int201211063063622353238
   PubMed Web of Science ®Google Scholar
• RigauMOlivanMGarciaMThe present and future of prostate cancer urine biomarkersInt J Mol Sci201314126201264923774836
   PubMedGoogle Scholar
• AndersonNLAndersonNGThe human plasma proteome: history, character, and diagnostic prospectsMol Cell Proteomics2002184586712488461
   PubMed Web of Science ®Google Scholar
• SchachtMJGarnettJEGrayhackJTBiochemical markers in prostatic-cancerUrol Clin North Am1984112532676203205
   PubMedGoogle Scholar
• WinnesMLissbrantEDamberJEStenmanGMolecular genetic analyses of the TMPRSS2-ERG and TMPRSS2-ETV1 gene fusions in 50 cases of prostate cancerOncol Rep2007171033103617390040
   PubMedGoogle Scholar
• DemichelisFFallKPernerSTMPRSS2: ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohortOncogene2007264596459917237811
   PubMed Web of Science ®Google Scholar
• ClarkJMersonSJhavarSDiversity of TMPRSS2-ERG fusion transcripts in the human prostateOncogene2007262667267317043636
   PubMedGoogle Scholar
• YoshimotoMJoshuaAMChilton-MacneillSThree-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangementNeoplasia2006846546916820092
   PubMed Web of Science ®Google Scholar
• ChinnaiyanAMRole of the TMPRSS2-ERG gene fusion in prostate cancerNeoplasia200810177U2318283340
   PubMedGoogle Scholar
• CerveiraNRibeiroFRPeixotoATMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesionsNeoplasia2006882683217032499
   PubMed Web of Science ®Google Scholar
• LapointeJKimYHMillerMAA variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosisMod Pathol20072046747317334351
   PubMedGoogle Scholar
• NamRKSugarLMKlotzLHVenkateswaranVSethAExpression of TMPRSS2: ERG gene fusion in prostate cancer cells is an important prognostic factor for cancer progressionJ Urol2007177467468
   Google Scholar
• SollerMJElfvingPLundgrenRPanagopolsIConfirmation of the high frequency of the TMPRSS2/ERG fusion gene in prostate cancerGenes Chromosomes Cancer20064571771916575875
   PubMedGoogle Scholar
• WangJHCaiYRenCXIttmannMExpression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancerCancer Res2006668347835116951141
   PubMed Web of Science ®Google Scholar
• PernerSDemichelisFBeroukhimRTMPRSS2: ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancerCancer Res2006668337834116951139
   PubMedGoogle Scholar
• IljinKWolfMEdgrenHTMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogrammingCancer Res200666102421024617079440
   PubMed Web of Science ®Google Scholar
• HermansKGvan MarionRvan DekkenHJensterGvan WeerdenWMTrapmanJTMPRSS2: ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancerCancer Res200666106581066317108102
   PubMedGoogle Scholar
• PernerSMosqueraJMDemichelisFTMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasionAm J Surg Pathol20073188288817527075
   PubMed Web of Science ®Google Scholar
• KannanKCoarfaCRajapaksheKCDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinomaPLoS Genet201410e100421624675677
   PubMedGoogle Scholar
• HesselsDSchalkenJAThe use of PCA3 in the diagnosis of prostate cancerNat Rev Urol2009625526119424173
   PubMed Web of Science ®Google Scholar
• WuGDatarRHHansenKMThundatTCoteRJMajumdarABioassay of prostate-specific antigen (PSA) using microcantileversNat Biotechnol20011985686011533645
   PubMed Web of Science ®Google Scholar
• WangHZhangYYuHLabel-free electrochemical immunosensor for prostate-specific antigen based on silver hybridized mesoporous silica nanoparticlesAnal Biochem201343412312723201390
   PubMedGoogle Scholar
• ChikkaveeraiahBVBhirdeAMalhotraRPatelVGutkindJSRuslingJFSingle-wall carbon nanotube forest arrays for immuno-electrochemical measurement of four protein biomarkers for prostate cancerAnal Chem2009819129913419775154
   PubMedGoogle Scholar
• HuangYWWuCSChuangCKReal-time and label-free detection of the prostate-specific antigen in human serum by a polycrystalline silicon nanowire field-effect transistor biosensorAnal Chem2013857912791823898965
   PubMedGoogle Scholar
• KokkinosCEconomouAPetrouPSKakabakosSEMicrofabricated tin-film electrodes for protein and DNA sensing based on stripping voltammetric detection of Cd(II) released from quantum dots labelsAnal Chem201385106861069124131278
   PubMed Web of Science ®Google Scholar
• KavosiBSalimiAHallajRAmaniKA highly sensitive prostate-specific antigen immunosensor based on gold nanoparticles/PAMAM dendrimer loaded on MWCNTS/chitosan/ionic liquid nanocompositeBiosens Bioelectron201452202824016535
   PubMed Web of Science ®Google Scholar
• KimJPLeeBYLeeJHongSSimSJEnhancement of sensitivity and specificity by surface modification of carbon nanotubes in diagnosis of prostate cancer based on carbon nanotube field effect transistorsBiosens Bioelectron2009243372337819481922
   PubMed Web of Science ®Google Scholar
• PaniniNVMessinaGASalinasEFernandezHRabaJIntegrated microfluidic systems with an immunosensor modified with carbon nanotubes for detection of prostate specific antigen (PSA) in human serum samplesBiosens Bioelectron2008231145115118162392
   PubMed Web of Science ®Google Scholar
• SalimiAKavosiBFathiFHallajRHighly sensitive immunosensing of prostate-specific antigen based on ionic liquid-carbon nanotubes modified electrode: application as cancer biomarker for prostate biopsiesBiosens Bioelectron20134243944623235113
   PubMed Web of Science ®Google Scholar
• HuangYWangTHJiangJHShenGLYuRQProstate specific antigen detection using microgapped electrode array immunosensor with enzymatic silver depositionClin Chem20095596497119264854
   PubMed Web of Science ®Google Scholar
• PandeyBDemchenkoAVStineKJNanoporous gold as a solid support for protein immobilization and development of an electrochemical immunoassay for prostate specific antigen and carcinoembryonic antigenMicrochim Acta20121797181
   Google Scholar
• TianJNHuangJLZhaoYCZhaoSLElectrochemical immunosen-sor for prostate-specific antigen using a glassy carbon electrode modified with a nanocomposite containing gold nanoparticles supported with starch-functionalized multi-walled carbon nanotubesMicrochim Acta20121788188
   Web of Science ®Google Scholar
• KumarVSrivastavaSUmraoSYadavRKNathGSumanaGNanostructured palladium-reduced graphene oxide platform for high sensitive, label free detection of a cancer biomarkerRSC Adv2014422672273
   Google Scholar
• QuBChuXShenGYuRA novel electrochemical immunosensor based on colabeled silica nanoparticles for determination of total prostate specific antigen in human serumTalanta20087678579018656659
   PubMed Web of Science ®Google Scholar
• TianCYZhaoWWWangJXuJJChenHYAmplified quenching of electrochemiluminescence from CdS sensitized TiO2 nanotubes by CdTe-carbon nanotube composite for detection of prostate protein antigen in serumAnalyst20121373070307522624149
   PubMed Web of Science ®Google Scholar
• ChangYFHungSHLeeYJDiscrimination of breast cancer by measuring prostate-specific antigen levels in women’s serumAnal Chem2011835324532821591802
   PubMedGoogle Scholar
• GaoZXuMHouLChenGTangDMagnetic bead-based reverse colorimetric immunoassay strategy for sensing biomoleculesAnal Chem2013856945695223806145
   PubMed Web of Science ®Google Scholar
• GrubishaDSLipertRJParkHYDriskellJPorterMDFemtomo-lar detection of prostate-specific antigen: an immunoassay based on surface-enhanced Raman scattering and immunogold labelsAnal Chem2003755936594314588035
   PubMed Web of Science ®Google Scholar
• ChenZLeiYChenXWangZLiuJAn aptamer based resonance light scattering assay of prostate specific antigenBiosens Bioelectron201236354022542926
   PubMed Web of Science ®Google Scholar
• HuangLReekmansGSaerensDProstate-specific antigen immunosensing based on mixed self-assembled monolayers, camel antibodies and colloidal gold enhanced sandwich assaysBiosens Bioelectron20052148349016076438
   PubMed Web of Science ®Google Scholar
• KongXLQiHZhouHXRenLLDengCYLiFRA novel sensitive immunoassay by nucleic acid barcode dot and its application in the detection of prostate-specific antigenClin Chem Lab Med20104827928320001442
   PubMed Web of Science ®Google Scholar
• SatoISagiMIshiwariANishijimaHItoEMukaiTUse of the “SMITEST” PSA card to identify the presence of prostate-specific antigen in semen and male urineForensic Sci Int2002127717412098528
   PubMedGoogle Scholar
• SatoIBarniFYoshiikeMApplicability of Nanotrap Sg as a semen detection kit before male-specific DNA profiling in sexual assaultsInt J Legal Med200712131531916583248
   PubMed Web of Science ®Google Scholar
• SatoIKojimaKYamasakiTRapid detection of semenogelin by one-step immunochromatographic assay for semen identificationJ Immunol Methods200428713714515099762
   PubMed Web of Science ®Google Scholar
• YuhiTNagataniNEndoTResin-based micropipette tip for immunochromatographic assays in urine samplesJ Immunol Methods2006312546016624320
   PubMedGoogle Scholar
• GeSGYuJHJiaoXLChenDRUltrasensitive electrochemiluminescence immunoassay for protein specific detection based on dendrimer-encapsulated gold nanoparticles labelsJ Inorg Organomet Polym Mater20132311131121
   Google Scholar
• ThaxtonCSElghanianRThomasADNanoparticle-based bio-barcode assay redefines “undetectable” PSA and biochemical recurrence after radical prostatectomyProc Natl Acad Sci U S A2009106184371844219841273
   PubMed Web of Science ®Google Scholar
• LiaoKTChengJTLiCLLiuRTHuangHJUltra-sensitive detection of mutated papillary thyroid carcinoma DNA using square wave stripping voltammetry method and amplified gold nanoparticle biomarkersBiosens Bioelectron2009241899190419010660
   PubMed Web of Science ®Google Scholar
• Gonzalez-GarciaMBFernandez-SanchezCCosta-GarciaAColloidal gold as an electrochemical label of streptavidin-biotin interactionBiosens Bioelectron20001531532111219743
   PubMed Web of Science ®Google Scholar
• DequaireMDegrandCLimogesBAn electrochemical metalloimmunoassay based on a colloidal gold labelAnal Chem2000725521552811101226
   PubMed Web of Science ®Google Scholar
• LiWGeSWangSYanMGeLYuJHighly sensitive chemiluminescence immunoassay on chitosan membrane modified paper platform using TiO2 nanoparticles/multiwalled carbon nanotubes as labelLuminescence20132849650223355319
   PubMedGoogle Scholar
• ChoiHKLeeJHRole of magnetic Fe3O4 graphene oxide in chemiluminescent aptasensors capable of sensing tumor markers in human serumAnal Methods2013569646968
   Google Scholar
• BrimanMArtukovicEZhangLChiaDGoodglickLGrunerGDirect electronic detection of prostate-specific antigen in serumSmall2007375876217352433
   PubMedGoogle Scholar
• LiWPElectropolymerized poly(3,4-ethylendioxythiophene)/graphene composite film and its application in quantum dots electro-chemiluminescence immunoassayJ Inorg Organomet Polym Mater201323719725
   Google Scholar
• KermanKEndoTTsukamotoMChikaeMTakamuraYTamiyaEQuantum dot-based immunosensor for the detection of prostate-specific antigen using fluorescence microscopyTalanta2007711494149919071481
   PubMed Web of Science ®Google Scholar
• HuhtinenPSoukkaTLovgrenTHarmaHImmunoassay of total prostate-specific antigen using europium(III) nanoparticle labels and streptavidin-biotin technologyJ Immunol Methods200429411112215604021
   PubMedGoogle Scholar
• AlhasanAHKimDYDanielWLScanometric MicroRNA array profiling of prostate cancer markers using spherical nucleic acid-gold nanoparticle conjugatesAnal Chem2012844153416022489825
   PubMed Web of Science ®Google Scholar
• TranHVPiroBReisbergSTranLDDucHTPhamMCLabel-free and reagentless electrochemical detection of microRNAs using a conducting polymer nanostructured by carbon nanotubes: application to prostate cancer biomarker miR-141Biosens Bioelectron20134916416923743328
   PubMedGoogle Scholar
• KimYJRahmanMMLeeJJUltrasensitive and label-free detection of annexin A3 based on quartz crystal microbalanceSensor Actuat B Chem2013177172177
   Web of Science ®Google Scholar
• SrinivasanBLiYJingYXingCSlatonJWangJPA three-layer competition-based giant magnetoresistive assay for direct quantification of endoglin from human urineAnal Chem2011832996300221417448
   PubMed Web of Science ®Google Scholar
• ArterJADiazJEDonavanKCYuanTPennerRMWeissGAVirus-polymer hybrid nanowires tailored to detect prostate-specific membrane antigenAnal Chem2012842776278322339784
   PubMedGoogle Scholar
• MohanKDonavanKCArterJAPennerRMWeissGASub-nanomolar detection of prostate-specific membrane antigen in synthetic urine by synergistic, dual-ligand phageJ Am Chem Soc20131357761776723614709
   PubMed Web of Science ®Google Scholar
• ZitkaOKrizkovaSKrejcovaLMicrofluidic tool based on the antibody-modified paramagnetic particles for detection of 8-hydroxy-2′-deoxyguanosine in urine of prostate cancer patientsElectrophoresis2011323207322022012838
   PubMedGoogle Scholar
• ZitkaOCerneiNHegerZMicrofluidic chip coupled with modified paramagnetic particles for sarcosine isolation in urineElectrophoresis2013342639264723775886
   PubMedGoogle Scholar
• O’RourkeDJDiJohnsonDACaiazzoRJJrAutoantibody signatures as biomarkers to distinguish prostate cancer from benign prostatic hyperplasia in patients with increased serum prostate specific antigenClin Chim Acta201241356156722146597
   PubMed Web of Science ®Google Scholar
• LernerMBD’SouzaJPazinaTHybrids of a genetically engineered antibody and a carbon nanotube transistor for detection of prostate cancer biomarkersACS Nano201265143514922575126
   PubMedGoogle Scholar
• GaoXZhangHLiYSuXMn-doped ZnSe d-dots-based alpha-methylacyl-CoA racemase probe for human prostate cancer cell imagingAnal Bioanal Chem20124021871187722241581
   PubMedGoogle Scholar
• HuoQLitherlandSASullivanSHallquistHDeckerDARivera-RamirezIDeveloping a nanoparticle test for prostate cancer scoringJ Transl Med2012104422404986
   PubMedGoogle Scholar
• FangCChenZLiLXiaJBarcode lateral flow immunochromato-graphic strip for prostate acid phosphatase determinationJ Pharm Biomed Anal2011561035104021880451
   PubMed Web of Science ®Google Scholar
• ChandaNShuklaRKattiKVKannanRGastrin releasing protein receptor specific gold nanorods: breast and prostate tumor avid nano-vectors for molecular imagingNano Lett200991798180519351145
   PubMed Web of Science ®Google Scholar
• HarisinghaniMGBarentszJHahnPFNoninvasive detection of clinically occult lymph-node metastases in prostate cancerN Engl J Med20033482491249912815134
   PubMed Web of Science ®Google Scholar
• TongSZhouXZhouCA strategy to decorate porous polymer monoliths with graphene oxide and graphene nanosheetsAnalyst20131381549155723350066
   PubMed Web of Science ®Google Scholar
• FanYChenXTriggADTungCHKongJGaoZDetection of microRNAs using target-guided formation of conducting polymer nanowires in nanogapsJ Am Chem Soc20071295437544317411036
   PubMed Web of Science ®Google Scholar